中文名称：洛沙坦
  • 2-丁基-4-氯-5-(羟甲基)-1-[[2'-(1H-四氮唑-5-)联苯基-4-]甲基]咪唑; 氯沙坦
  • Losartan
  • 2-butyl-4-chloro-1-[p-(o-1h-tetrazol-5-ylphenyl)benzyl]imidazole-5- methanol; (2-butyl-4-chloro-1-{[2'-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol; [2-butyl-5-chloro-3-[[4-phenyl-3-(1H-tetrazol-5-yl)phenyl]methyl]imidazol-4-yl]methanol; Losartan base
  • 114798-26-4
  • C22H23ClN6O
  • 422.9106
  • InChI=1/C22H23ClN6O/c1-2-3-9-20-24-21(23)19(14-30)29(20)13-15-10-11-17(16-7-5-4-6-8-16)18(12-15)22-25-27-28-26-22/h4-8,10-12,30H,2-3,9,13-14H2,1H3,(H,25,26,27,28)
  • 洛沙坦 114798-26-4
  • 1.35g/cm3
  • 686.5°C at 760 mmHg
  • 369°C
  • 8.63E-20mmHg at 25°C
  • 第一个口服非肽类血管紧张素Ⅱ受体拮抗剂。主要用于原发性高血压。